Clinical trials
Completed Stomach Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| Novartis Pharmaceuticals | 4 |
| Royal Marsden NHS Foundation Trust | 4 |
| Eli Lilly and Company | 3 |
| Merck KGaA, Darmstadt, Germany | 3 |
| Bayer | 2 |
| BeiGene | 2 |
| Bristol-Myers Squibb | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 59 |
| Esophageal Neoplasms | 13 |
| Ovarian Neoplasms | 7 |
| Breast Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Adenocarcinoma | 4 |
| Sarcoma | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Endometrial Neoplasms | 3 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.